Not in isolation, or one marker at a time
Preclinical studies have suggested potential biomarkers such as circulating free IGF levels, mutations of p53, BRCA1, KRAS and BRAF, IRS2 copy number gain, InsR/IGF-IR overexpression, InsR/IGF-IR pathway activation, PTEN loss, CD24, mesenchymal markers, -catenin/TCF activity, FUS-DDIT3 fusion, and ERG [192,193,194,195,196,197,198,199,200,201]
Compounded Glutathione Injection: Quality Standards at MediVera Compounded glutathione injections are not FDA-approved thats the baseline fact of the category
PMID: 22537212 | DOI: 10.1111/j.1753-4887.2012.00476.x [21] Machowetz A, Poulsen HE, Gruendel S, et al
The induction of human superoxide dismutase and catalase in vivo : A fundamentally new approach to antioxidant therapy